Understanding potential side effects is crucial
Disclosures: Jessica Mellinger: GlaxoSmithKline: Advisor, Tingting Liu: Nothing to Disclose, Haila Asefa: Nothing to Disclose, Patricia Bloom: Vedanta Biosciences: Research grant, Nexilico: Consultant, Sal Giorgi: Nothing to Disclose, Brenda Curtis: Nothing to Disclose 2219 DISTRIBUTION OF ORGANISMS IN PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS: A VETERAN'S HEALTH COHORT STUDY Nadim Mahmud 1 Natalia Salinas Parra 2 Aaron Hecht 3 David Kaplan 3 Marina Serper 4 , 1 Hospital of the University of Pennsylvania, 2 Hospital of the University of Pennyslvania, 3 University of Pennsylvania, 4 University of Pennsylvania Health System Background: Spontaneous bacterial peritonitis (SBP) is a common complication of decompensated cirrhosis with a high mortality rate
Mice were placed in the center of the open field with lights on and then allowed to explore for 5 minutes
Ernie Blevins, an endocrinologist at the University of Washington, and his colleagues co-administered oxytocin and a low dose of tirzepatide, a dual agonist mimicking the effects of both GLP-1 and glucose-dependent insulinotropic polypeptide, to obese rats and discovered that together, they produced more pronounced weight loss than either treatment alone
Clinical implications for perioperative care Why does IGE matter in surgery
[15] [16] However, some observational studies have suggested a modest elevation in risk
